Aytu BioPharma (AYTU) is a company investors believe would of prevented the COVID-19 coronavirus pandemic from spreading in its early stages, however the tests and products the company sold should of told investors that it wasn’t a profitable investment from the start.
The company sold generic COVID-19 Chinese tests that claimed to detect COVID-19 in blood in under 15 minutes, however other companies also bought the same test from China and most of them where giving false positives. Although Aytu did not buy it from the same companies in China that were giving false positives, the tests were obviously the same but manufactured by different Chinese companies.
Having been generic Chinese tests, AYTU stock didn’t have much action. Investors gained hope of the company getting a shoutout from the Trump administration because he said he would want to bring “light inside the body,” investors were once again excited, however that ended in a huge disappointment.
After all these occurrences, investors has lost confidence in AYTU stock. The company seems to have more downside than upside in my opinion.